Jeffrey Bedrosian, MD
Otolaryngology · Portland, MENPI 1821252974
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $534,769 of the $727,496 with a category attached, or 73.5%. 31 manufacturers reported payments, led by Optinose US, Inc. at 46.5% of the total. 2025 is the largest year on record at $246,608, 3.7 times the $66,336 reported in 2019. Among otolaryngology clinicians in ME with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 920 payments — averaging $790.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Optinose US, Inc.$339K
- Regeneron Healthcare Solutions, Inc.$121K
- Sanofi$99K
- GSK$95K
- Medical Device Business Services, Inc.$43K
- Neurent Medical Limited$23K
- plus $8K from 25 others
Across 14 payments — averaging $10,039 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Optinose US, Inc.$130K
- AstraZeneca$10K
What the payments were for
- Consulting fees$76,24010%
- Speaking & faculty fees$534,76974%
- Travel & lodging$88,83712%
- Food & beverage$27,6134%
- Education$340%
- Gifts$40%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Optinose US, Inc. | 410 | $338,569 |
| Regeneron Healthcare Solutions, Inc. | 111 | $120,932 |
| Sanofi | 81 | $99,042 |
| GSK | 119 | $94,532 |
| Medical Device Business Services, Inc. | 53 | $43,446 |
| Neurent Medical Limited | 60 | $22,646 |
| Acclarent, Inc | 11 | $4,799 |
| Medtronic(2 entities) | 11 | $1,213 |
| Aerin Medical Inc. | 9 | $531 |
| Intersect ENT, Inc. | 9 | $431 |
| Stryker | 6 | $287 |
| 3-d Matrix, Inc. | 1 | $265 |
| Organogenesis Inc. | 5 | $181 |
| Pfizer | 7 | $104 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $89 |
| Regeneron | 2 | $88 |
| Paratek Pharmaceuticals, Inc. | 2 | $49 |
| Merck | 3 | $45 |
| Amgen | 1 | $34 |
| Hologic Sales And Service, LLC | 2 | $29 |
| Alk-abello, Inc | 2 | $29 |
| Axogen | 1 | $22 |
| Biohaven Pharmaceuticals, Inc. | 1 | $20 |
| Cook Medical LLC | 1 | $19 |
| Omeros Corporation | 1 | $18 |
| Integra Lifesciences Corporation | 1 | $17 |
| AstraZeneca | 1 | $14 |
| Novartis | 1 | $14 |
| Covidien LP | 1 | $14 |
| Atos Medical Inc | 1 | $11 |
| Phathom Pharmaceuticals, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Xhance$333,316
- DUPIXENT$303,065
- NUCALA$92,100
- NEUROMARK Device$20,462
- NEUROMARK Radiofrequency Console$17,893
- TruDi Nav Suction$10,304
- TruDi Nav Cable$10,232
- ACCLARENT NAVWIRE Sinus Navigation Guidewire$10,005
- TruDi Navigation System$9,889
- ACCLARENT Balloon Inflation Device$4,250
- NEUROMARK Radiofrequency Generator$3,280
- SpinPlus Navigation$1,400
- TruDi$1,400
- NEUROMARK System$710
- PROPEL$452
- VIVAER STYLUS$308
- RHINAER STYLUS$308
- NUVENT$250
- Acclarent Aera$228
- SCOPIS ENT$164
How this compares
$727,496 in reported general payments places this provider in the 95th percentile of 42 otolaryngology providers in Maine.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 164 | $4,778 |
| Famotidine | 294 | $2,980 |
| Pantoprazole Sodium | 51 | $368 |
| Azelastine Hcl | 20 | $325 |
| Omeprazole | 66 | $278 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 24 | $178 |
| Nortriptyline Hcl | 22 | $164 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 30 | $105 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 17 | $89 |
| Prednisone | 27 | $59 |
| Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid | 15 | $38 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Portland
- Stephen MaturoPortland$14K
- David ThomsonPortland$519
- Kevin BurkePortland$129
- Frederick RoedigerPortland$0
- Matthew HearstPortland$0
- Peter O'ConnorBrunswick$27K
- Elizabeth PearceFalmouth$5K
- William ReedScarborough$4K
- Brian CusickAugusta$4K
- Rebecca HarveyScarborough$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.